A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)
Clinical trial NCT00927511 · UNKNOWN
Trial details
- NCT number
- NCT00927511
- Sponsor
- Regina Elena Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2012-04-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.